Medidata Release: MCT-Congress Announces World-Class Line-Up For 2015 Event
Two-day event will explore the realities of using mobile technology in clinical trials
21 October 2014 - Edinburgh, Scotland - MCT-Congress, a two-day event dedicated to the business of mobile technology in the clinical trial space, has announced a world-class line-up for its 2015 congress. Bringing together providers, sponsors, academics, investors and regulators, including those who are shaping the direction of mobile in clinical trials, and those who are taking their first steps into exploring this exciting field, the meeting will provide a hotbed of discussion and business. The congress will connect key-players and thought leaders from around the world, all with the shared goal of taking the industry forward in the adoption of mobile technology. The congress will take place at the Edinburgh International Conference Centre (EICC), 24th-25th March 2015.
Sponsored by Medidata for the second year running, the MCT-Congress 2015 will deliver a dynamic and energetic programme centred around key issues, including the psychology and design of mobile devices, mHealth strategy within clinical trials, regulatory barriers and opportunities, data deluge management and interpretation, as well as the realities of the on-site adoption of mobile technologies. The only event to bring together experts from every aspect of clinical trial innovation, the MCT-Congress will offer delegates thought-provoking speaker sessions on this growing market, industry success stories and new innovations, while looking at how the industry can accelerate growth within the boundaries of current regulations. Over thirty experts representing CROs, pharma, telecomms, clinicians and regulators will share their knowledge and experience, including:
- Glen de Vries, President of Medidata
- Tim Davis, CEO, Exco InTouch
- Craig Lipset, Head of Clinical Innovation, Pfizer
- Jeff Lee, Founder of mProve
- Marc Buyse, Founder of IDDI & CluePoints
- Johann Proeve, Global Strategy & Development Advisor, Bayer Healthcare
“At Medidata, we believe transforming clinical trials means connecting patients with their families, communities and care providers in new and innovative ways. One way is through mobile technology, to improve patient engagement, adherence, and outcomes,” Glen de Vries, president of Medidata, explained. “We’re looking forward to MCT 2015, and to discussing the benefits and challenges of using mobile technologies in clinical research.”
Edinburgh's Award-winning International Conference Centre will play host to the MCT-Congress 2015, 24-25th March. To register for a place, please visit www.mct-congress.co.uk or call Veronique Madsen on +44(0)7866 782165
Help employers find you! Check out all the jobs and post your resume.
21 October 2014 - Edinburgh, Scotland - MCT-Congress, a two-day event dedicated to the business of mobile technology in the clinical trial space, has announced a world-class line-up for its 2015 congress. Bringing together providers, sponsors, academics, investors and regulators, including those who are shaping the direction of mobile in clinical trials, and those who are taking their first steps into exploring this exciting field, the meeting will provide a hotbed of discussion and business. The congress will connect key-players and thought leaders from around the world, all with the shared goal of taking the industry forward in the adoption of mobile technology. The congress will take place at the Edinburgh International Conference Centre (EICC), 24th-25th March 2015.
Sponsored by Medidata for the second year running, the MCT-Congress 2015 will deliver a dynamic and energetic programme centred around key issues, including the psychology and design of mobile devices, mHealth strategy within clinical trials, regulatory barriers and opportunities, data deluge management and interpretation, as well as the realities of the on-site adoption of mobile technologies. The only event to bring together experts from every aspect of clinical trial innovation, the MCT-Congress will offer delegates thought-provoking speaker sessions on this growing market, industry success stories and new innovations, while looking at how the industry can accelerate growth within the boundaries of current regulations. Over thirty experts representing CROs, pharma, telecomms, clinicians and regulators will share their knowledge and experience, including:
- Glen de Vries, President of Medidata
- Tim Davis, CEO, Exco InTouch
- Craig Lipset, Head of Clinical Innovation, Pfizer
- Jeff Lee, Founder of mProve
- Marc Buyse, Founder of IDDI & CluePoints
- Johann Proeve, Global Strategy & Development Advisor, Bayer Healthcare
“At Medidata, we believe transforming clinical trials means connecting patients with their families, communities and care providers in new and innovative ways. One way is through mobile technology, to improve patient engagement, adherence, and outcomes,” Glen de Vries, president of Medidata, explained. “We’re looking forward to MCT 2015, and to discussing the benefits and challenges of using mobile technologies in clinical research.”
Edinburgh's Award-winning International Conference Centre will play host to the MCT-Congress 2015, 24-25th March. To register for a place, please visit www.mct-congress.co.uk or call Veronique Madsen on +44(0)7866 782165
Help employers find you! Check out all the jobs and post your resume.